Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis

Authors

Kathleen W. Zhang, Washington University School of Medicine in St. Louis
Keith E. Stockerl-Goldstein, Washington University School of Medicine in St. Louis
Daniel J. Lenihan, Washington University School of Medicine in St. Louis

Journal

JACC: Basic to Translational Science

Publication Date

2019

Volume

4

Issue

3

Inclusive Pages

438-448

Document Type

Open Access Publication

DOI

10.1016/j.jacbts.2019.02.002

Rights and Permissions

Zhang KW, Stockerl-Goldstein KE, and Lenihan DJ (2019) Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis. JACC: Basic to Translational Science, 4(3):438-448. https://doi.org/10.1016/j.jacbts.2019.02.002 Copyright 2019 THE AUTHORS. PUBLISHED BY ELSEVIER ON BEHALF OF THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION. THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Zhang, Kathleen W.; Stockerl-Goldstein, Keith E.; and Lenihan, Daniel J., "Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis." JACC: Basic to Translational Science. 4, 3. 438-448. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7947